Urgent need to expand use of shingles vaccine and treat shingles-related pain

October 24, 2012 in Diseases, Conditions, Syndromes

Shingles, a reactivation of the herpes zoster (chickenpox) virus affects nearly 1 in 3 Americans. About 1 million cases are diagnosed each year, with some patients suffering excruciating pain and itching due to post-herpetic neuralgia (PHN), a complication of the viral infection that can last for years despite treatment. The latest information on shingles and PHN, including a new, improved vaccine to prevent shingles and alternative therapies to control symptoms, are discussed in a special focus section in Population Health Management, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

The issue features an interview with Julie Gerberding, MD, MPH, president of the vaccines unit of Merck (MRK), the company that manufactures the vaccine, and former director of the Centers for Disease Control (CDC). It also includes a Roundtable discussion featuring a panel comprised of some of the world's leading experts on PHN including Rafael Harpaz, MD, from the Centers for Disease Control; an article on the biology underlying reactivation of the zoster virus; and a study focused on the role that nutrition may have in shingles therapy. Barbara Yawn, MD, MSc, Director of Research, Olmsted Medical Center and Adjunct Professor, Department of Family and Community Health, University of Minnesota, Rochester, MN, is the guest editor of the special section.

"Shingles can be a devastating condition, especially for who have a 30% chance of continuing to have the often debilitating pain of PHN," says Guest Editor Dr. Yawn. "This is a condition that deserves continuing attention from the public, physicians, and nurses, as well as researchers."

"This issue of is especially valuable because it captures the extensive research taking place on shingles and PHN, in addition to the treatment options that have been shown to reduce dramatically the number of shingles cases," says Editor-in-Chief David B. Nash, MD, MBA, Dean and Dr. Raymond C. and Doris N. Grandon Professor, Jefferson School of , Philadelphia, PA.

More information: The articles in this special section are available free on the Population Health Management website at www.liebertpub.com/pop.

Provided by Mary Ann Liebert, Inc./Genetic Engineering News

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Researchers find genetic risk factor for pulmonary fibrosis

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...

Diseases, Conditions, Syndromes created 9 hours ago | popularity not rated yet | comments 0

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

Diseases, Conditions, Syndromes created 9 hours ago | popularity 5 / 5 (1) | comments 0

CDC says high number of public pools contain microbes

(HealthDay)—Three-quarters of public schools in the metro Atlanta area contain microbes, including bacteria indicating the presence of fecal matter, according to research published in the May 17 issue of ...

Diseases, Conditions, Syndromes created 10 hours ago | popularity not rated yet | comments 0

Study examines outbreak of spinal infections in Michigan

(HealthDay)—Factors such as increased case finding may explain why Michigan had half of the total spinal infections associated with contaminated methylprednisolone acetate in the recent fungal meningitis ...

Diseases, Conditions, Syndromes created 10 hours ago | popularity not rated yet | comments 0

World not ready for mass flu outbreak, WHO says

The world is unprepared for a massive virus outbreak, the deputy chief of the World Health Organization warned Tuesday, amid fears that H7N9 bird flu striking China could morph into a form that spreads easily among people.

Diseases, Conditions, Syndromes created 11 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.